Catramilast
Catramilast is a PDE4D inhibitor. Catramilast can be used in pain research[1].
Product Specifications
CAS Number
[183659-72-5]
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Neurological Disease
Smiles
COC(C=CC([C@H](C)CN1C(NC=C1)=O)=C2)=C2OCC3CC3
Molecular Formula
C17H22N2O3
Molecular Weight
302.37
References & Citations
[1]Class IP, USPC A. Patent application title: Compounds and methods for treating pain inventors: Josef Penninger (Vienna, AT) Josef Penninger (Vienna, AT) Graham Gregory Neely (Sydney, AU) Shane Mcmanus (Vienna, AT) Henrik Nilsson (Vienna, AT) . The Journal of Pharmacology and Experimental Therapeutics. 2013 Sep 26.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
